Jake Bieber-Dishart is a Senior Associate at Samsara and joined the firm in 2025. Prior to Samsara, Jake was an Associate at Apple Tree Partners where he helped create multiple companies to advance novel medicines. Jake was first introduced to biotechnology investing at RTW investments, where he evaluated promising drug targets apt for therapeutic development.
Jake received his B.S. in Chemical and Biomolecular Engineering from the Johns Hopkins University and earned his Ph.D. in Bioengineering jointly from the University of California, Berkeley and the University of California, San Francisco, where he was also awarded the ARCS scholarship. For his PhD, Jake developed a high-throughput gut organoid system to screen drugs for gastrointestinal toxicity.